Medy-Tox reported second-quarter consolidated operating profit of 4.76 billion won ($3.36 million), down 24.6 percent from a year earlier, according to a regulatory filing Monday.
Revenue for the same period rose 11.4 percent to 68.72 billion won.
Net profit for the period came in at 3.13 billion won, a preliminary figure reflecting a 61.7 percent decline from a year earlier.
jiyoon436@heraldcorp.com
